Literature DB >> 31102510

Prognostic Accuracy of Soluble Triggering Receptor Expressed on Myeloid Cells (sTREM-1)-based Algorithms in Febrile Adults Presenting to Tanzanian Outpatient Clinics.

Melissa Richard-Greenblatt1, Noémie Boillat-Blanco2, Kathleen Zhong1, Zainab Mbarack3, Josephine Samaka4, Tarsis Mlaganile4, Thekla Kazimoto4, Valerie D'acremont5,6, Kevin C Kain7.   

Abstract

BACKGROUND: The inability to identify individuals with acute fever at risk of death is a barrier to effective triage and management of severe infections, especially in low-resource settings. Since endothelial and immune activation contribute to the pathogenesis of various distinct life-threatening infections, we hypothesized that measuring mediators of these pathways at clinical presentation would identify febrile adults at risk of death.
METHODS: Plasma concentrations of markers of endothelial (angiopoetin-1/2, soluble fms-like tyrosine kinase-1, soluble vascular cell adhesion molecule-1, soluble intercellular adhesion molecule-1) and immune (soluble triggering receptor expressed on myeloid cells [sTREM-1], interleukin-6, interleukin-8, chitinase-3-like protein-1, soluble tumor necrosis factor receptor-1, procalcitonin [PCT], C-reactive protein [CRP]) activation pathways were determined in consecutive adults with acute fever (≥38°C) at presentation to outpatient clinics in Dar es Salaam, Tanzania. We evaluated the accuracy of these mediators in predicting all-cause mortality and examined whether markers could improve the prognostic accuracy of clinical scoring systems, including the quick sequential organ failure assessment (qSOFA) and Glasgow coma scale (GCS).
RESULTS: Of 507 febrile adults, 32 died (6.3%) within 28 days of presentation. We found that sTREM-1 was the best prognostic marker for 28-day mortality (area under the receiver operating characteristic [AUROC] 0.87, 95% confidence interval [CI] 0.81-0.92) and was significantly better than CRP (P < .0001) and PCT (P = .0001). The prognostic accuracy of qSOFA and the GCS were significantly enhanced when sTREM-1 was added (0.80 [95% CI 0.76-0.83] to 0.91 [95% CI 0.88-0.94; P < .05] and 0.72 [95% CI 0.63-0.80] to 0.94 [95% CI 0.91-0.97; P < .05], respectively).
CONCLUSIONS: Measuring sTREM-1 at clinical presentation can identify febrile individuals at risk of all-cause febrile mortality. Adding severity markers such as sTREM-1 to simple clinical scores could improve the recognition and triage of patients with life-threatening infections in resource-limited settings. © Crown copyright 2019.

Entities:  

Keywords:  biomarker-based algorithms; qSOFA; resource-limited; severe infection

Mesh:

Substances:

Year:  2020        PMID: 31102510     DOI: 10.1093/cid/ciz419

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  16 in total

1.  Fever in returning travellers and migrants: disease severity markers to improve triage and management.

Authors:  Michelle Ngai; Kevin C Kain
Journal:  J Travel Med       Date:  2020-09-26       Impact factor: 8.490

2.  Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness project.

Authors:  Arjun Chandna; Rusheng Chew; Nan Shwe Nwe Htun; Thomas J Peto; Meiwen Zhang; Marco Liverani; Tobias Brummaier; Koukeo Phommasone; Carlo Perrone; Aung Pyae Phyo; Jetsumon Sattabongkot; Wanlapa Roobsoong; Wang Nguitragool; Aninda Sen; Sazid Ibna Zaman; Aye Sandar Zaw; Elizabeth Batty; Naomi Waithira; Mohammad Yazid Abdad; Stuart D Blacksell; Ladaporn Bodhidatta; James J Callery; Watcharintorn Fagnark; Witchayoot Huangsuranun; Shayla Islam; Sanchai Lertcharoenchoke; Salisa Lohavittayavikant; Mavuto Mukaka; Vanna Moul; Amit Kumer Neogi; Supalert Nedsuwan; Tiengkham Pongvongsa; Pimsiri Ponsap; Melissa Richard-Greenblatt; William H K Schilling; Janjira Thaipadungpanit; Rupam Tripura; Arjen M Dondorp; Mayfong Mayxay; Nicholas J White; François Nosten; Frank Smithuis; Elizabeth A Ashley; Richard J Maude; Nicholas P J Day; Yoel Lubell
Journal:  Wellcome Open Res       Date:  2022-03-10

3.  Practical Methods to Permit the Analysis of Host Biomarkers in Resource-Limited Settings.

Authors:  Arjun Chandna; Melissa Richard-Greenblatt; Richard Tustin; Sue J Lee; Kevin C Kain; Sakib Burza; Yoel Lubell; Paul Turner
Journal:  Am J Trop Med Hyg       Date:  2022-04-18       Impact factor: 3.707

4.  sTREM-1 predicts mortality in hospitalized patients with infection in a tropical, middle-income country.

Authors:  Shelton W Wright; Lara Lovelace-Macon; Viriya Hantrakun; Kristina E Rudd; Prapit Teparrukkul; Susanna Kosamo; W Conrad Liles; Direk Limmathurotsakul; T Eoin West
Journal:  BMC Med       Date:  2020-07-01       Impact factor: 8.775

5.  Is Malaria an Important Cause of Death among Adults?

Authors:  Hellen Gelband; Isaac I Bogoch; Peter S Rodriguez; Michelle Ngai; Nazia Peer; Leah K Watson; Prabhat Jha
Journal:  Am J Trop Med Hyg       Date:  2020-04-16       Impact factor: 2.345

Review 6.  New insights into microvascular injury to inform enhanced diagnostics and therapeutics for severe malaria.

Authors:  Clara Erice; Kevin C Kain
Journal:  Virulence       Date:  2019-12       Impact factor: 5.882

7.  Prediction of disease severity in young children presenting with acute febrile illness in resource-limited settings: a protocol for a prospective observational study.

Authors:  Sakib Burza; Yoel Lubell; Arjun Chandna; Endashaw M Aderie; Riris Ahmad; Eggi Arguni; Elizabeth A Ashley; Tanya Cope; Vu Quoc Dat; Nicholas P J Day; Arjen M Dondorp; Victor Illanes; Joanne De Jesus; Carolina Jimenez; Kevin Kain; Keang Suy; Constantinos Koshiaris; Estrella Lasry; Mayfong Mayxay; Dinesh Mondal; Rafael Perera; Tiengkham Pongvongsa; Sayaphet Rattanavong; Michael Rekart; Melissa Richard-Greenblatt; Mohammad Shomik; Phouthalavanh Souvannasing; Veronica Tallo; Claudia Turner; Paul Turner; Naomi Waithira; James A Watson; Mikhael Yosia
Journal:  BMJ Open       Date:  2021-01-25       Impact factor: 2.692

8.  COVID-19 risk stratification algorithms based on sTREM-1 and IL-6 in emergency department.

Authors:  Mathias Van Singer; Thomas Brahier; Michelle Ngai; Julie Wright; Andrea M Weckman; Clara Erice; Jean-Yves Meuwly; Olivier Hugli; Kevin C Kain; Noémie Boillat-Blanco
Journal:  J Allergy Clin Immunol       Date:  2020-10-09       Impact factor: 10.793

9.  Potential role of Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) in SARS-CoV-2 infection: First insights.

Authors:  Ayane de Sá Resende; Yrna Lorena Matos de Oliveira; Tatiana Rodrigues de Moura; Paulo Ricardo Martins-Filho
Journal:  EXCLI J       Date:  2021-03-26       Impact factor: 4.068

10.  Anticipating the future: prognostic tools as a complementary strategy to improve care for patients with febrile illnesses in resource-limited settings.

Authors:  Arjun Chandna; Jennifer Osborn; Quique Bassat; David Bell; Sakib Burza; Valérie D'Acremont; B Leticia Fernandez-Carballo; Kevin C Kain; Mayfong Mayxay; Matthew Wiens; Sabine Dittrich
Journal:  BMJ Glob Health       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.